Skip to main content

Table 1 Demographics and clinical characteristics between the ICG and non-ICG groups

From: The short-term and long-term outcomes of indocyanine green tracer-guided laparoscopic radical gastrectomy in patients with gastric cancer

  ICG (n = 28) Non-ICG (n = 28) P value
Age (yrs.) 57.96±12.66 59.17±9.17 0.6874
Gender (male, %) 19 (67.86%) 20 (71.43%) 0.7713
ASA-PS    >0.9999
 II 13 (46.43%) 13 (46.43%) -
 III 15 (53.57%) 15 (53.57%) -
BMI (kg/m2) 22.25±2.32 22.86±2.73 0.3716
Tumor location    0.2049
 Upper third 7 (25.00%) 10 (35.71%) -
 Middle third 11 (39.29%) 5 (17.86%) -
 Lower third 10 (35.71%) 13 (46.43%) -
cT stage    0.7744
 cT1 17 (60.72%) 19 (67.86%) -
 cT2 8 (28.57%) 5 (17.86%) -
 cT3 3 (10.71%) 3 (10.71%) -
 cT4 0 1 (3.57%) -
cN stage    >0.9999
 cN0 20 (71.43%) 20 (71.43%) -
 cN+ 8 (28.57%) 8 (28.57%) -
Clinical stage    0.6862
 I+II 25 (89.29%) 24 (85.71%) -
 III+IV 3 (10.71%) 4 (14.29%) -
Histological type    0.5920
 Well/Moderate 14 (50.00%) 12 (42.86%) -
 Poor/Undifferentiated 14 (50.00%) 16 (57.14%) -
  1. TNM staging was based on the Japanese Classification of Gastric Carcinoma, 3rd English version
  2. ASA-PS The American Society of Anesthesiology Physical Status Classification